跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tobidina - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tobidina
Approved
STANDARD
Tobidina
Indiana Ophthalmics.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4fa22c9ae5202882
Company
Indiana Ophthalmics.
Type
Standard
Approval Details
Approval Id
4fa22c9ae5202882
Drug Approval Philippines Name
Tobidina
Product Name
Tobidina
Registration Number
DRP-15875
Brand Name
Tobidina
Generic Name
Tobramycin (as sulfate)
Dosage Form
Ophthalmic Solution
Dosage Strength
3 mg/mL (0.3% w/v)
Manufacturer
Indiana Ophthalmics.
Importer
Aglobal Care, Inc.
Distributor
Aglobal Care, Inc.
Issuance Date
25 September 2024
Expiry Date
25 September 2029
Pharmacologic Category
Antibacterial
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4fa22c9ae5202882
Type
Standard
Back to Philippines FDA Approvals